Followers | 237 |
Posts | 10817 |
Boards Moderated | 0 |
Alias Born | 07/17/2006 |
Tuesday, May 04, 2021 9:35:33 AM
At first glance this appears to be a typical SA hatchet job, but careful examination indicates the hatchet is not very sharp and BNGO's illness is more like Acne and not cancer..'
The major thrust of the SA article is that BNGO's revenues are not that impressive at present...This of course is no surprise in medicine..The oath reminds all clinicians that experiment is perilous. My professors at HMS always warned us that we should never be the first in our area to adopt new technology..
The SA article notes BNGO has counterfeited its revenues by issuing secondary's that dilute shareholders. And have sugar coated its predictions of sales of equipment. What the article down plays is that BNGO's superior technology...Put simply it's optical system can do things the gene sequencers can not...These include identifying neonatal genetic pr0blems, proclivity to cancer and even whether or not a patient will have a serious case of CV-19...
The paper also notes that BNGO has not been FDA approved for treatment but only for diagnosis. And many insurance plans will not cover treatments that lack FDA approval...Medical devices are not subject to the rigors of the FDA drug marketing process and approvals are largely based on safety issues. And as such the approval time is only a fraction of the three phases that drugs must survive..
Yes Saphyr is the new kid on the block... But make no mistake..Saphyr is better in many ways a is definitely the future...
":>) JL
Recent BNGO News
- Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/08/2024 09:27:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:09:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:02:28 PM
- Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress • GlobeNewswire Inc. • 05/08/2024 08:01:00 PM
- Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference • GlobeNewswire Inc. • 04/30/2024 08:05:00 PM
- Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing • GlobeNewswire Inc. • 04/24/2024 12:00:00 PM
- Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/04/2024 05:44:35 PM
- Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance • GlobeNewswire Inc. • 03/19/2024 12:00:00 PM
- Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System • GlobeNewswire Inc. • 03/07/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:48:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:47:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:44:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:26:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:23:48 PM
- Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Bionano to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 01:16:10 PM
- Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024 • GlobeNewswire Inc. • 02/28/2024 01:01:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM